Daily Anesthesiology Research Analysis
Three impactful anesthesiology-related studies stood out today: a two-centre prospective cohort validated the EACTS algorithm for defining perioperative myocardial infarction after cardiac surgery, a randomized trial showed continuous magnesium infusion markedly reduces postoperative atrial fibrillation after off-pump CABG, and a meta-analysis found pecto-intercostal fascia plane block significantly lowers opioid use and shortens time to extubation after sternotomy. Collectively, these works ref
Summary
Three impactful anesthesiology-related studies stood out today: a two-centre prospective cohort validated the EACTS algorithm for defining perioperative myocardial infarction after cardiac surgery, a randomized trial showed continuous magnesium infusion markedly reduces postoperative atrial fibrillation after off-pump CABG, and a meta-analysis found pecto-intercostal fascia plane block significantly lowers opioid use and shortens time to extubation after sternotomy. Collectively, these works refine perioperative definitions, prevent arrhythmias, and advance opioid-sparing analgesia.
Research Themes
- Perioperative cardiac injury definitions and risk stratification
- Prevention of postoperative atrial fibrillation after cardiac surgery
- Opioid-sparing regional anesthesia for sternotomy
Selected Articles
1. Redefinition of Myocardial Infarction After Cardiac Surgery: A two-centre Clinical Evaluation of the Proposed European Association for Cardio-thoracic Surgery Algorithm for the Diagnosis of Perioperative Myocardial Injury and Infarction.
In 1,142 cardiac surgery patients, the EACTS algorithm yielded a similar PMI incidence as the 4th Universal Definition but reduced perioperative myocardial injury classification from 87.2% to 29.9%, while preserving strong associations with 1-year mortality. This supports adopting the EACTS criteria to avoid overclassification without losing prognostic signal.
Impact: This large prospective cohort refines perioperative cardiac injury definitions, directly impacting trial endpoints, quality metrics, and postoperative cardiac care pathways.
Clinical Implications: Adopting the EACTS algorithm can reduce labeling bias in ‘myocardial injury’ after cardiac surgery while maintaining mortality risk stratification, potentially improving clinical decision-making and endpoint integrity in trials and quality programs.
Key Findings
- PMI incidence was similar by EACTS vs 4UD (2.5% vs 2.6%).
- Myocardial injury classification dropped from 87.2% (4UD) to 29.9% (EACTS).
- EACTS-defined PMI retained strong 1-year mortality association (adjusted HR 12.3).
Methodological Strengths
- Prospective, two-centre cohort with large sample size (n=1142).
- Adjusted mortality analyses (EuroSCORE II) across biomarker strata.
Limitations
- Non-randomized observational design limits causal inference.
- External validation beyond two centres and varied surgical populations is needed.
Future Directions: Validate EACTS thresholds across broader institutions and integrate into perioperative pathways; assess downstream effects on management, resource use, and clinical trial endpoint performance.
OBJECTIVE: This study evaluated the clinical applicability and relevance of the European Association for Cardio-thoracic Surgery (EACTS) algorithm for the diagnosis of perioperative myocardial injury and myocardial infarction (PMI) after cardiac surgery, compared to the Fourth Universal Definition of Myocardial Infarction (4UD). DESIGN: This was a prospective two-centre cohort study in adults undergoing a range of elective and urgent cardiac surgeries. PMI and myocardial injury were diagnosed using both the EACTS algorithm and the 4UD. Primary outcome was to compare PMI and myocardial injury incidences between definitions. One-year mortality hazard ratios (HRs) adjusted for EuroSCORE II were calculated for perioperative biomarker elevation, myocardial injury, and PMI versus no myocardial injury. RESULTS: In total, 1142 patients were included. Most common procedures were coronary artery bypass grafting (53.0%) and isolated valve surgery (24.4%). The EACTS algorithm diagnosed 2.5% (n = 28) of patients as PMI (vs 2.6%, n = 30 with 4UD), 29.9% (n = 341) as myocardial injury (vs 87.2%, n = 996 with 4UD), 37.6% (n = 429) as perioperative biomarker elevation, and 30.1% (n = 344) as no myocardial injury (vs 10.2%, n = 116 with 4UD). Adjusted HRs for 1-year mortality with the EACTS algorithm were 12.3 (95% CI, 2.0-74.7) for PMI (vs 13.7 [95% CI, 1.5-124.6] with 4UD), 3.6 (95% CI, 0.8-16.6) for myocardial injury (vs 2.3 [95% CI, 0.3-17.0] with 4UD), and 2.7 (95% CI, 0.6-12.6) for perioperative biomarker elevation. CONCLUSIONS: Implementation of the EACTS algorithm led to a similar incidence of PMI but substantially reduced myocardial injury incidence compared to the 4UD while maintaining its clinically relevant association with mortality.
2. The Effect of Continuous Magnesium Infusion to Prevent Postoperative Atrial Fibrillation in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.
In a randomized trial of 104 OP-CABG patients, continuous magnesium infusion (target 1.5–2 mmol/L) reduced POAF from 19.2% to 1.9% without increasing ICU stay or vasoactive requirements. Magnesium also reduced the need for additional antiarrhythmic pharmacotherapy.
Impact: Demonstrates a simple, scalable preventive strategy for a common and morbid postoperative arrhythmia without apparent hemodynamic penalty.
Clinical Implications: Consider protocolized postoperative magnesium supplementation with serum level targets (1.5–2 mmol/L) after OP-CABG to prevent POAF, while monitoring for adverse effects.
Key Findings
- POAF incidence dropped from 19.2% (control) to 1.9% with continuous magnesium (P=0.008).
- Need for additional antiarrhythmic pharmacotherapy decreased (15.4% vs 1.9%; P=0.031).
- No significant differences in cardioversion, ICU length of stay, or VIS max.
Methodological Strengths
- Randomized controlled design with defined serum magnesium targets.
- Clinically meaningful endpoints (POAF, ICU stay, vasoactive use).
Limitations
- Single-centre trial with modest sample size.
- Blinding and detailed adverse event profiling not clearly reported.
Future Directions: Multicentre RCTs to validate dosing/targets, evaluate long-term outcomes, and compare with other POAF prophylaxis strategies (e.g., beta-blockers, amiodarone).
INTRODUCTION: Postoperative atrial fibrillation (POAF), which occurs in almost 20-40% of cardiac surgeries, is associated with life-threatening complications. Serum hypomagnesemia, a frequent finding after cardiac surgeries, is a predictor for POAF. In this study, we investigated the effect of continuous magnesium infusion to prevent POAF in patients undergoing off-pump coronary artery bypass grafting (OP-CABG). MATERIALS AND METHODS: A prospective, randomized controlled study was conducted on 110 patients undergoing OP-CABG. Patients were classified into two groups after reaching the intensive care unit (ICU). Group M was started on magnesium (Mg) infusion at 750 mg/h for 3 days after an initial bolus dose of 1.5 g of magnesium sulfate, to target a serum magnesium level of 1.5 to 2 mmol/L. The control group (Group C) did not receive any infusion. The incidence of POAF, magnesium values, duration of ICU stay, number of patients who required pharmacotherapy and cardioversion, and maximum vasoactive-inotropic score (VIS max) were recorded. A P <.05 was taken as statistically significant. RESULTS: 104 patients were analyzed. The incidence of POAF (19.2% vs 1.9%, P = .008) and the number of patients requiring pharmacotherapy other than magnesium (15.4% vs 1.9%, P = .0310) were significantly higher in group C. Mean of peak magnesium values (1.624 ± 0.136 vs 0.710 ± 0.147, P < .001) was significantly higher in Group M. The number of patients requiring cardioversion (P = .618), duration of ICU stay (P = .121), and the VIS max (P = .360) were not significantly different between groups. CONCLUSION: Postoperative continuous magnesium infusion after a bolus was effective in preventing POAF in patients undergoing OP-CABG by maintaining serum magnesium levels (1.5-2 mmol/).
3. Effectiveness of Pecto-Intercostal Fascia Plane Block in Reducing Total Postoperative Opioid Consumption in Cardiac Surgery Involving Sternotomy: A Meta-Analysis.
Across 16 studies, PIFB significantly reduced postoperative opioid consumption (SMD −1.55) and time to extubation (SMD −1.22) after sternotomy. Effects were consistent in ultrasound-guided subsets and with different injection strategies.
Impact: Provides quantitative synthesis supporting adoption of a simple parasternal fascial plane block to achieve opioid-sparing analgesia and faster recovery in cardiac surgery.
Clinical Implications: Incorporate ultrasound-guided PIFB into multimodal analgesia pathways for sternotomy to reduce opioid exposure and facilitate earlier extubation.
Key Findings
- PIFB reduced total postoperative opioid consumption (SMD −1.55; 95% CI −2.15 to −0.95).
- PIFB shortened time to extubation (SMD −1.22; 95% CI −2.05 to −0.38).
- Benefits persisted in ultrasound-guided-only analyses (opioids SMD −1.18; extubation SMD −0.82).
Methodological Strengths
- Systematic synthesis with random-effects modeling and subgroup analyses.
- Consistency across ultrasound-guided studies supports generalizability.
Limitations
- Clinical and methodological heterogeneity across included studies.
- Variability in local anesthetic regimens and opioid conversion metrics.
Future Directions: Head-to-head RCTs versus other parasternal blocks, dose-optimization studies, and evaluation of patient-centred outcomes (PONV, mobility, chronic pain).
The pecto-intercostal fascia plane block (PIFB) is gaining recognition for its potential to reduce postoperative opioid use after cardiac surgery. This study aimed to evaluate the effectiveness of PIFB compared with conventional intravenous regimens in reducing total postoperative opioid consumption in patients undergoing cardiac surgery involving sternotomy. A meta-analysis of relevant studies, published up to August 13, 2024, retrieved from the PubMed and CENTRAL databases was performed. The inclusion criteria were studies involving a superficial parasternal block or PIFB for patients undergoing cardiac surgery involving sternotomy. Studies comparing PIFB with other blocks or local anesthetic regimens were excluded. Data analysis was performed using an inverse variance random-effects model using RevMan 5.4.1 software, with the effect measure expressed as standardized mean difference (SMD) to account for the different opioids used. Of 88 studies retrieved in the literature search, 16 fulfilled the inclusion criteria [ten ultrasound (US)-guided and six non-US-guided]. PIFB significantly reduced total opioid consumption [SMD -1.55 (95% CI -2.15 to -0.95); P < 0.001] and time to extubation [SMD -1.22 (95% CI -2.05 to -0.38); P < 0.001]. A subgroup analysis of multiple- versus single-shot injections yielded consistent results. Analyses including only US-guided PIFB revealed consistent reductions in total opioid consumption [SMD -1.18 (95% CI -1.79 to -0.56); P < 0.001] and time to extubation [SMD -0.82 (95% CI -1.01 to -0.63); P < 0.001]. PIFB effectively reduced opioid consumption and shortened postoperative time to extubation in cardiac surgery involving sternotomy.